Latest News
Investor Relations
Latest News
December 16, 2022 07:30 am
BioStem Technologies Announces Up-Listing to the OTCQB Venture Market
December 14, 2022 07:30 am
BioStem Technologies Announces Partnership with Kill Cliff FC
November 15, 2022 04:05 pm
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
November 15, 2022 07:30 am
BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call
October 26, 2022 07:30 am
BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
October 10, 2022 07:30 am
BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
September 13, 2022 07:30 am
BioStem Announces Publication of a Standardized Method to Evaluate Growth Factor Elution from Placental Tissue Allografts
September 8, 2022 07:30 am
BioStem Technologies Strengthens its Board of Directors and Audit Committee with the Appointment of Accomplished Medtech Financial Leader Brandon Poe
August 22, 2022 04:01 pm